Navigation Links
Resverlogix Presents Key Apo-Al/HDL Scientific Data at DALM
Date:10/4/2007

TSX Exchange Symbol: RVX

CALGARY, Oct. 4 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce today that the Company is making an oral presentation of key scientific data of its lead clinical candidate, RVX-208, at the 16th International Symposium for Drugs Affecting Lipid Metabolism (DALM). The presentation titled, "A novel drug RVX-208 raises plasma apolipoprotein A-l and HDL cholesterol", will be presented by Dr. Norman Wong on October 4, 2007 at the Hilton Hotel in New York City.

"DALM is a premier international conference renowned for its content of state of the art therapeutics for the prevention of atherosclerosis and other cardiovascular diseases. We are pleased that Resverlogix will present its data detailing RVX-208, a small molecule drug which enhances the production of ApoA-l and HDL," stated Dr. Jan Johansson, Senior Vice President of Clinical Affairs of Resverlogix. Dr. Johansson added, "The scientific community recognizes the importance of a small molecule in the form of an oral tablet that significantly increases ApoA-I production, thereby enhancing the function of HDL. These beneficial effects of RVX-208 will potentially reduce the risk of atherosclerosis and cardiovascular disease."

About Resverlogix Corp.

Resverlogix Corp. is a leading biotechnology company engaged in the development of novel therapies for important global medical markets with significant unmet needs. The NexVas(TM) program is the Company's primary focus which is to develop novel small molecules that enhance ApoA-l. These vital therapies address the grievous burden of atherosclerosis and other important diseases such as acute coronary syndrome, diabetes, Alzheimer's and other vascular disorders. The Company's secondary focus is TGF-Beta Shield(TM), a program that aims to address burgeoning grievous diseases, such as cancer and fibrosis. Resverlogix Corp. trades on the Toronto Stock Exchange (TSX:RVX). For further information please visit http://www.resverlogix.com.

This news release may contain certain forward-looking statements that reflect the current views and/or expectations of Resverlogix Corp. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly. The TSX Exchange does not accept responsibility for the adequacy or accuracy of this news release.

Note to editors: Ken Lebioda, Senior Vice-President, will be attending the conference and can meet in person with interested media.


'/>"/>
SOURCE Resverlogix Corp.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. NimbleGen presents new tech for comparing microbe DNA
2. Wisconsin Technology Network presents symposium on saving lives by the use of Information Technology
3. Thieme Presents Unique Technology Angle at Gov.s Conference
4. UW-Madisons Beebe wins scientific award
5. Researchers say scientific reporting needs more perspective, less hype
6. Wisconsin stands at the center of scientific efforts to avert flu epidemics
7. Growth prompts new location for scientific instrument manufacturer
8. UW stem cell guru outlines scientific and political future
9. Wisconsin biotech sector featured in scientific magazine
10. Scientific Protein Laboratories Acquired by New York firm
11. GenTel Appoints Burke to its Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Fort Collins, Colorado (PRWEB) , ... December 06, ... ... developer of dynamic aqueous plasma technology platforms, announced today that the company has ... five-year Master Research and Development Agreement (MRDA) with the CSU Office of the ...
(Date:12/6/2016)... Zimmer Biomet Holdings, Inc. (NYSE and ... terms of its previously-announced cash tender offers (the ... (excluding accrued and unpaid interest to, but not ... and expenses related to the Offers) (the "Maximum ... the table below (collectively, the "Notes"). The terms ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... management solutions headquartered in Aurora, Ohio, announced the opening of their new office ... the newly constructed facility is home to 200 employees focused on providing sales, ...
(Date:12/5/2016)... ... December 05, 2016 , ... The Real Dirt with Chip ... technology and application experts, Chip Baker. Chip Baker formerly co-founded Royal Gold Soil ... 30 years, Chip Baker other industry veterans have made the evolution of cannabis ...
Breaking Biology Technology:
(Date:6/15/2016)... 15, 2016 Transparency Market ... Recognition Market by Application Market - Global Industry Analysis Size ... to the report, the  global gesture recognition market ... and is estimated to grow at a CAGR ... 2024.  Increasing application of gesture recognition ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
Breaking Biology News(10 mins):